Esther Martinborough
Director/Board Member at CODEXIS, INC.
Net worth: 153 522 $ as of 2024-04-29
Network origin in Esther Martinborough first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
26
| Subsidiary | Pharmaceuticals: Major | 26 |
| Public Company | Chemicals: Specialty | 23 | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA.
10
| Holding Company | Biotechnology | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Esther Martinborough via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Treasurer Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Administrative Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| AIMMUNE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| METACRINE, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst | |
| FATE THERAPEUTICS, INC. | Biotechnology | Chairman Chief Executive Officer Chief Executive Officer | |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
| BOUNDLESS BIO, INC. | Biotechnology | Comptroller/Controller/Auditor Director/Board Member Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
National Resilience, Inc.
 National Resilience, Inc. Miscellaneous Commercial ServicesCommercial Services National Resilience, Inc. is a biopharmaceutical manufacturing and technology company, which engages in the development of vaccines. It offers virus production, formulations, RNA modalities, and CMC development. The company was founded in 2020 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Haas School of Business | College/University | Masters Business Admin Masters Business Admin | |
| UCLA Anderson School of Management | College/University | Corporate Officer/Principal Masters Business Admin | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| BEAM THERAPEUTICS INC. | Biotechnology | Director/Board Member Director/Board Member | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member Director/Board Member | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Corporate Officer/Principal | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor |
Statistics
International
| United States | 49 |
| Denmark | 3 |
Sectoral
| Health Technology | 35 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 393 |
| Corporate Officer/Principal | 153 |
| Independent Dir/Board Member | 129 |
| Chairman | 66 |
| Chief Executive Officer | 63 |
Most connected contacts
| Insiders | |
|---|---|
| Amir Nashat | 49 |
| Douglas Cole | 44 |
| Kristina Burow | 40 |
| Richard Heyman | 33 |
| Patrick Yang | 28 |
| Faheem Hasnain | 27 |
| Mary Lynne Hedley | 25 |
| William Rastetter | 24 |
| Dennis Wolf | 23 |
| Rahul Singhvi | 22 |
| H. Parker | 22 |
| Jason Hafler | 21 |
| S. Torres | 21 |
| Mary Szela | 19 |
| Sheila Gujrathi | 18 |
- Stock Market
- Insiders
- Esther Martinborough
- Company connections
